Comparative study of the bioactivity of the HFA Fluticasone Dipropionate via current delivery devices

Registry ID

EUCTR2005-004475-37

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

University of Dundee ( Research & Innovation Services)

Start date

2005-11-28

Completion date

2007-04-20

Last update

2026-08-16

Conditions

• Bronchial Asthma

Summary

To compare the bioactivity of the inhaled steroid fluticasone dipropionate by the current delivery devices ( Evohaler, Aerochamber Plus and Neohaler)

Locations

• , , UK

Related clinical trials

• Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
• N95 Masks for Lung Health While Golfing During Wildfire Season
• Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.
• Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
• Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
• Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

View on source registry